
### [MONDO:0008567](http://purl.obolibrary.org/obo/MONDO_0008567)
**Label:** thyroid cancer, nonmedullary, 1

**Subclasses:** [MONDO:0011836](http://purl.obolibrary.org/obo/MONDO_0011836) (thyroid Hurthle cell carcinoma), [MONDO:0014681](http://purl.obolibrary.org/obo/MONDO_0014681) (thyroid cancer, nonmedullary, 4), [MONDO:0014682](http://purl.obolibrary.org/obo/MONDO_0014682) (thyroid cancer, nonmedullary, 5), [MONDO:0017895](http://purl.obolibrary.org/obo/MONDO_0017895) (familial papillary or follicular thyroid carcinoma), [MONDO:0011368](http://purl.obolibrary.org/obo/MONDO_0011368) (papillary thyroid Microcarcinoma), [MONDO:0008566](http://purl.obolibrary.org/obo/MONDO_0008566) (thyroid cancer, nonmedullary, 2), [MONDO:0011312](http://purl.obolibrary.org/obo/MONDO_0011312) (thyroid carcinoma, nonmedullary, with or without cell oxyphilia), [MONDO:0011653](http://purl.obolibrary.org/obo/MONDO_0011653) (NMTC3), [MONDO:0015447](http://purl.obolibrary.org/obo/MONDO_0015447) (differentiated thyroid carcinoma), 

**Corr. equiv. classes:** [OMIM:616534](http://purl.obolibrary.org/obo/OMIM_616534), [Orphanet:146](http://www.orpha.net/ORDO/Orphanet_146), [OMIM:603386](http://purl.obolibrary.org/obo/OMIM_603386), [OMIM:603744](http://purl.obolibrary.org/obo/OMIM_603744), [OMIM:616535](http://purl.obolibrary.org/obo/OMIM_616535), [OMIM:607464](http://purl.obolibrary.org/obo/OMIM_607464), [OMIM:188470](http://purl.obolibrary.org/obo/OMIM_188470), [Orphanet:319487](http://www.orpha.net/ORDO/Orphanet_319487), [OMIM:606240](http://purl.obolibrary.org/obo/OMIM_606240), 

**Class expressions from DL-Learner:**

- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 48.95%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology))) 48.04%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 47.29%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 42.78%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology))) 41.67%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) 40.48%
- [HP:0100031](http://purl.obolibrary.org/obo/HP_0100031) (Neoplasm of the thyroid gland) 36.97%
- [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 36.66%
- [HP:0000820](http://purl.obolibrary.org/obo/HP_0000820) (Abnormality of the thyroid gland) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 35.35%
- [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 34.17%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) 34.17%
- [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 31.31%
- [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) 31.13%
- [HP:0000820](http://purl.obolibrary.org/obo/HP_0000820) (Abnormality of the thyroid gland) 27.94%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 25.61%


